Sialoadhesin-positive host macrophages play an essential role in graft- versus-leukemia reactivity in mice

Blood

Volumn 93, Issue 12, 1999, Pages 4375-4386

  Müerköster, Susanne ^b   Rocha, Marian ^b   Crocker, Paul R ^b   Schirrmacher, Volker ^b   Umansky, Victor ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; CD4 ANTIGEN; CD8 ANTIGEN; CELL ADHESION MOLECULE; EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY; SIALOADHESIN;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GRAFT VERSUS LEUKEMIA EFFECT; HOST CELL; KUPFFER CELL; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR REGRESSION;

EID: 0344223247     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.12.4375.412k32_4375_4386     Document Type: Article

References (46)

1. Crocket PR, Gordon S: Properties and distribution of a lectin-like hemagglutinin differentially expressed by stromal tissue macrophages. J Exp Med 164:1862, 1986
2. Crocker PR, Gordon S: Mouse macrophage hemagglutinin (sheep erythrocyte receptor) with specificity for sialylated glycoconjugates characterized by a monoclonal antibody. J Exp Med 169:133, 1989
3. Crocker PR, Kelm S, Dubois C, Martin B, McWilliams AS, Shorten D, Paulso JC, Gordon S: Purification and properties of sialoadhesin, a sialic acid-binding receptor of murine tissue macrophages. EMBO J 10:1661, 1991
4. van den Berg TK, Breve JJP, Damoiseaux JGMC, Döpp EA, Kelm S, Crocker PR, Dijkstra CD, Kraal G: Sialoadhesin on macrophages: Its identification as a lymphocyte adhesion molecule. J Exp Med 176:647, 1992
5. Schirrmacher V, Beckhove P, Krüger A, Rocha M, Umansky V, Fichtner KP, Hull WE, Zangemeister-Wittke U, Griesbach A, Jurianz K, von Hoegen P: Effective immune rejection of advanced metastasized cancer. Int J Oncol 6:505, 1995
6. Schirrmacher V, von Hoegen P, Griesbach A, Schil HJ, Zangemeister-Wittke U: Specific eradication of micrometastases by transfer of tumour-immune T cells from major-histocompatibility-complex congenie mice. Cancer Immunol Immunother 32:37, 1991
7. Bosslet K, Schirrmacher V, Snatz G: Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. VI. Similar specificity patterns of protective anti-tumor immunity in vivo and of cytolytic T cells in vitro. Int J Cancer 24:303, 1979
8. von Hoegen P, Altevogt P, Schirrmacher V: New antigens presented on tumor cells can cause immune rejection without influencing the frequency of tumor-specific cytolytic T cells. Cell Immunol 109:333, 1987
9. Rocha M, Umansky V, Lee K, Hacker HJ, Benner A, Schirrmacher V: Differences between graft-versus leukemia and graft-versus host reactivity. 1. Interaction of donor immune T cells with tumor and/or host cells. Blood 89:2189, 1997
10. Umansky V, Beckhove P, Rocha M, Krüger A, Crocker PR, Schirrmacher V: A role for sialoadhesin-positive tissue macrophages in host resistance to lymphoma metastasis in vivo. Immunology 87:303, 1996
11. Townsend ARM, Bodmer H: Antigen recognition by class I-restricted T lymphocytes. Annu Rev Immunol 7:601, 1989
12. Germain RM, Margiles DH: The biochemistry and cell biology of antigen presentation. Annu Rev Immunol 11:403, 1993
13. Bachmann MF, Kundig TM, Freer G, Li Y, Kang CY, Bishop DH, Hengartner H, Zinkernagel RM: Induction of protective cytotoxic T cells with viral proteins. Eur J Immunol 24:2228, 1994
14. Huang AYC, Golumbek P, Ahmadzadeh M, Jaffee E, Pardoll D, Levitsky H: Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 264:961, 1994
15. Rock KL, Rothstein L, Gamble S, Fleischacker C: Characterization of antigen-presenting cells that present exogenous antigens in association with class I MHC molecules. J Immunol 150:438, 1993
16. Reimann J, Kaufmann SH: Alternative antigen processing pathways in anti-infective immunity. Curr Opin Immunol 9:462, 1997
17. Falo LD, Kovacsovics-Bankowski M, Thompson K, Rock KL: Targeting antigen into phagocytic pathway in vivo induces protective tumour immunity. Nat Med 1:649, 1995
18. Watts C: Capture and processing of exogenous antigens for presentation on MHC molecules. Annu Rev Immunol 15:821, 1997
19. Brossart P, Bevan MJ: Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells: pathway of presentation and regulation by cytokines. Blood 90:1594, 1997
20. Lanzavecchia A: Mechanisms of antigen uptake for presentation. Curr Opin Immunol 8:348, 1996
21. Kovacsovics-Bankowski M, Rock KL: A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 267:243, 1995
22. Pfeifer JD, Wick MJ, Roberts RL, Findla K, Normar SJ, Harding CV: Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 361:359, 1993
23. Suto R, Srivastava PK: A mechanism for the specific immunogenicity of heat-shock protein-chaperoned peptides. Science 269:1585, 1995
24. Krüger A, Schirrmacher V, von Hoegen P: Scattered micrometastasis visualized at the single-cell level: Detection and re-isolation of lacZ-labeled metastasized lymphoma cells. Int J Cancer 58:275, 1994
25. Benke R, Lang E, Komitowski D, Muto S, Schirrmacher V: Changes in tumor cell adhesiveness affecting speed of dissemination and mode of metastatic growth. Invasion Metastasis 8:159, 1988
26. Carbone FR, Bevan MJ: Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo. J Exp Med 171:377, 1990
27. Schirrmacher V, Leidig S, Griesbach A: In situ activation of syngeneic tumour-specific cytotoxic T lymphocytes: Intra-pinna immunization followed by restimulation in the peritoneal cavity. Cancer Immunol Immunother 33:299, 1991
28. - variants of a cloned cytolytic T cell line lack an antigen receptor functional in cytolysis. J Exp Med 153:595, 1981
29. Ledbetter JA, Herzenberg LA: Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol Rev 47:63, 1979
30. Kincade PU, Lee GL, Watanabe T, Sun L, Scheid M: Antigens displayed on murine B-lymphocyte precursosrs. J Immunol 127:2262, 1981
31. Austyn JM, Gordon S: F4/80: A monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol 1:805, 1981
32. Razi-Wolf Z, Freeman G, Galvin F, Benacerraf B, Nadler L, Reiser H: Expression and junction of the murine B7 antigen, the major costimulatory molecule expressed by peritoneal exudate cells. J Exp Med 89:4210, 1992
33. Arnold B, Horstmann U, Kuon W, Burgert HG, Hämmerling GJ, Kvist S: Alloreactive T-cell clones preferentially recognize conformational determinants on histocompatibility antigens: Analysis with genetically engineered hybrid antigens. Proc Natl Acad Sci USA 82:7030, 1985
34. van Voorhis WC, Hair LS, Steinman RM, Kapla G: Human dendritic cells. Enrichment and characterization from peripheral blood. J Exp Med 155:1172, 1982
35. van Roojien N, Sanders AM: Liposome mediated depletion of macrophages: Mechanism of action, preparation of liposomes and applications. J Immunol Methods 17:83, 1994
36. Rocha M, Krüger A, van Rooijen N, Schirrmacher V, Umansky V: Liver endothelial cells participate in T cell dependent host resistance to lymphoma metastasis by production of nitric oxide in vivo. Int J Cancer 63:405, 1995
37. Van Rooijen N, Sanders A: Elimination, blocking, and activation of macrophages: Three of a kind? J Leukoc Biol 47:251, 1997
38. Krenacs T, Krenacs L, Bpzoky B, Ivanyi B: Double and triple immunocytochemical labeling at the light microscopic level in histopathology. Histochem J 22:530, 1990
39. Müerköster S, Wachowski O, Zerban H, Schirrmacher V, Umansky V, Rocha M: GvL reactivity involves cluster formation between superantigen-reactive donor T lymphocytes and host macrophages. Clin Cancer Res 4:3095, 1998.
40. Rammensee HG, Schil HJ, Theopold U: Protein-specific cytotoxic T lymphocytes. Recognition of transfectants expressing intracellular, membrane-associated or secreted forms of β-galactosidase. Immunogenetics 30:296, 1989
41. Schirrmacher V, Beutner U, Bucur M, Umansky V, Rocha M, von Hoegen P: Loss of endogenous mouse mammary tumor virus superantigen increases tumor resistance. J Immunol 161:563, 1998
42. Luther SA, Acha-Orbea H: Mouse mammary tumor virus: Immunological interplays between virus and host. Adv Immunol 65:139, 1997
43. Pierre P, Turkley SJ, Gatti E, Hull M, Meltzer J, Mizra A, Inaba K, Steinman RM, Mellman I: Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 388:787, 1997
44. Norbury CC, Hewlett LJ, Prescott AR, Shastri N, Watts C: Class IMHC presentation of exogenous soluble antigen via micropinocytosis in bone marrow macrophages. Immunity 3:783, 1995
45. Oh YK, Harding CV, Swanson JA: The efficiency of antigen delivery from macrophage phagosomes into cytoplasm for MHC class I-restricted antigen presentation. Vaccine 15:511, 1997
46. Arnold D, Faath S, Rammensee HG, Schild HJ: Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96. J Exp Med 182:885, 1995